How can the VAP Test help customize patient treatment?

The availability of more sophisticated cholesterol treatments points to broader use of the VAP Test because results will help physicians more specifically match a drug or combination of drugs with a patients cholesterol profile. The VAP Tests breakdown of lipid subfractions is vital in determining appropriate treatments. For example, elevated Lp(a) doubles the risk for CAD and requires niacin, fenofibrate, estrogen, or N-3 PUFAs (fish oils). IDL is 10 times more atherogenic than LDL on a mg for mg basis and requires a statin plus niacin in combination. For more information, click here to request a free copy of Using VAP Expanded Lipid Testing to Develop Optimal Patient Treatment Plans by lipid expert Paul Ziajka, M.D., Ph.D.